Skip to main content


The Artificial Heart market faces significant challenges despite advancements. Issues like durability, power sources, and compatibility hinder widespread adoption. Implant rejection and infection risks persist, demanding better biocompatibility and infection control measures. High costs pose accessibility barriers, limiting patient reach. Additionally, regulatory hurdles and ethical concerns surrounding long-term implications require thorough addressing. Addressing these challenges is crucial for realizing the potential of artificial hearts in revolutionizing cardiac care.